Menu Search
Equities

ProAssurance Corp

PRK:FRA

ProAssurance Corp

Actions
  • Price (EUR)16.20
  • Today's Change0.00 / 0.00%
  • Shares traded205.00
  • 1 Year change+33.88%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 15:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ProAssurance Corporation is a specialty insurer with expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers' compensation insurance. The Company's segments include Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance and Corporate. The Specialty Property and Casualty (Specialty P&C) segment is focused on professional liability insurance and medical technology liability insurance. Professional liability insurance is offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. The Workers' Compensation Insurance segment offers workers' compensation products in approximately 19 states in the East, South and Midwest regions of the continental United States. The Segregated Portfolio Cell Reinsurance segment includes the results of SPCs at Inova Re and Eastern Re, the Company's Cayman Islands SPC operations.

  • Revenue in USD (TTM)1.15bn
  • Net income in USD42.95m
  • Incorporated2000
  • Employees1.09k
  • Location
    ProAssurance Corp100 Brookwood PlBIRMINGHAM 35209-6811United StatesUSA
  • Phone+1 (205) 877-4400
  • Fax+1 (205) 868-4073
  • Websitehttps://www.proassurance.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.